Clinical Trials on Steatohepatitis, Nonalcoholic
Total 718 results
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
University of AarhusCompletedNASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseDenmark
-
Massachusetts General HospitalCompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Massachusetts General HospitalUniversity of California, San Diego; Foundation for the National Institutes...CompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Yokohama City UniversityEA Pharma Co., Ltd.CompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverJapan
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
Melinta Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
National Institute of Diabetes and Digestive and...University of California, San Diego; The Cleveland Clinic; Duke University; University... and other collaboratorsRecruitingNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Massachusetts General HospitalRecruitingNAFLD | NASH - Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
University of California, San DiegoRecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver | Liver Inflammation | Liver FibrosesUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownDiabetes type2 | NAFLD | NASH - Nonalcoholic Steatohepatitis
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic CirrhosisUnited States, Japan
-
Bristol-Myers SquibbCompletedNAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisHungary, Czechia
-
Regeneron PharmaceuticalsNot yet recruitingNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD) | Genetic Risk Factor
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Zydus Therapeutics Inc.CompletedNonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
NorgineCompletedNonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Johannes Gutenberg University MainzGoethe UniversityCompletedDiabetes Mellitus, Type 2 | Hyperlipidemias | NASH - Nonalcoholic SteatohepatitisGermany
-
University of Missouri-ColumbiaEnrolling by invitationMetabolic Syndrome | Obesity, Morbid | NASH - Nonalcoholic SteatohepatitisUnited States
-
Tiziana Life Sciences LTDWithdrawnNAFLD | NASH - Nonalcoholic Steatohepatitis | T2DM (Type 2 Diabetes Mellitus)
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
National Institute of Diabetes and Digestive and...Completed
-
Keith Pereira, MD:Not yet recruitingObesity | Body Weight | Weight Loss | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Cirius Therapeutics, Inc.Not yet recruitingType2 Diabetes | Nonalcoholic Steatohepatitis | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease
-
Yokohama City UniversityActive, not recruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverJapan
-
West German Center of Diabetes and HealthRecruiting
-
VA Office of Research and DevelopmentCompletedNonalcoholic SteatohepatitisUnited States
-
Galectin Therapeutics Inc.Active, not recruitingCirrhosis | NASH - Nonalcoholic Steatohepatitis | Prevention of Esophageal VaricesUnited States, France, Spain, Australia, Canada, Israel, Puerto Rico, Belgium, Argentina, Chile, Germany, Korea, Republic of, Mexico, Poland, United Kingdom
-
Getz PharmaRecruitingDiabetes Mellitus, Type 2 | NAFLD | NASH - Nonalcoholic SteatohepatitisPakistan
-
Metacrine, Inc.Active, not recruitingDiabetes | Fatty Liver | Type 2 Diabetes | NAFLD | NASH - Nonalcoholic Steatohepatitis | Diabetes Type 2 | NASH | Fatty Liver, NonalcoholicUnited States
-
Zydus Therapeutics Inc.RecruitingNonalcoholic SteatohepatitisUnited States
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Massachusetts General HospitalGE HealthcareRecruitingFatty Liver | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
ChemomAb Ltd.CompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC) | Systemic Sclerosis (SSc)Israel
-
Hepion Pharmaceuticals, Inc.CompletedFibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
University of Missouri-ColumbiaCompletedObesity | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
RWTH Aachen UniversityUnknownObesity | Bariatric Surgery Candidate | Nonalcoholic SteatohepatitisGermany
-
NorgineCompletedNonalcoholic Steatohepatitis | Hepatic CirrhosisBulgaria
-
Galectin Therapeutics Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
Sheffield Teaching Hospitals NHS Foundation TrustBayerCompletedHypogonadism | Nonalcoholic SteatohepatitisUnited Kingdom
-
Sheba Medical CenterCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisIsrael
-
Intercept PharmaceuticalsCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
Catalysis SLCompletedInsulin Resistance | Nonalcoholic SteatohepatitisCuba
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain